MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202617095433 A) filed by Shanghai Argo Biopharmaceutical Co. , Ltd. on August 06, 2026, for Compositions And Methods For Inhibiting Expression Of Transmembrane Serine Protease 6 (tmprss6).
Inventors include Shu, Dongxu; Shao, Pengcheng Patrick; and Xia, Shiwei.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: Compositions and methods useful to reduce expression of transmembrane serine protease 6 (TMPRSS6) gene and for treatment of TMPRSS6-associated diseases and conditions are provided. Provided are TMPRSS6 dsRNA agents, TMPRSS6 antisense polynucleotide agents, compositions comprising TMPRSS6 dsRNA agents, and compositions comprising TMPRSS6 antisense polynucleotide agents that can be used to reduce TMPRSS6 expression in cells and subjects.
Disclaimer: Curated by HT Syndication.
